普通人群中精神病风险标志物的研究综述
本文综述了基于普通人群(非求助者)的精神病维度研究,关注精神病谱系症状、神经认知缺陷及神经影像等标志物。多数研究为横断面设计且工具重叠有限,但症状、认知与脑结构/功能/连接异常方面呈现一致发现,支持在发育背景下研究精神病体验的效度。
要点
- 普通人群研究多采用问卷和维度方法评估精神病体验,与临床高危求助者研究形成互补。
- 一致发现包括神经认知缺陷及与痛苦、功能损害相关的脑结构、功能和连接异常。
- 需更多社区纵向研究并标准化工具,以建立精神病出现的发育轨迹和风险/韧性标志物。
核心结论
- 普通人群中精神病体验的研究结果与精神分裂症相关异常文献一致,支持其效度。
- 需要更多社区纵向研究以建立发育轨迹并识别风险与韧性标志物。
研究设计与样本
- 本文为综述,聚焦普通人群中非求助者的精神病维度研究。
- 多数纳入研究为横断面设计,依赖问卷且工具重叠有限。
主要发现
- 症状、神经认知缺陷、神经影像参数及其他生物标志物与精神病特征的出现和持续存在相关。
- 异常包括神经认知缺陷及与痛苦、损害和功能结局相关的脑结构、功能和连接异常。
临床怎么用
- 支持在普通人群中以维度方法研究精神病体验,以描绘其在一般精神病理背景下的出现。
- 提示需推进社区研究的标准化、工具统一和纵向随访,以连接细胞分子异常与精神病表现。
局限性
- 多数研究为横断面设计,无法确立发育轨迹或机制联系。
- 研究工具重叠有限,缺乏标准化和统一化测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The categorical approach to defining schizophrenia spectrum disorders requires meeting established criteria. To advance early identification and intervention in young people, the field has progressed to studying help-seeking individuals who are at clinical high risk based on subthreshold psychosis spectrum symptoms, and criteria have been articulated for qualifying individuals as at risk. A broader dimensional examination of psychosis has been applied to population-based studies on non-help seekers. This review highlights the ascertainment and assessment approaches to such population-based studies. Most studies are cross-sectional and rely on questionnaires with limited overlap of tools. However, several consistent findings emerge on symptoms, neurocognitive deficits, and neuroimaging parameters and other biomarkers associated with emergence and persistence of psychotic features. The findings are consistent with the literature on abnormalities associated with schizophrenia, including the presence of neurocognitive deficits; abnormalities in brain structure, function, and connectivity that are related to distress; impairment; and functional outcome. These findings support the validity of studying psychosis experiences during development in a way that can chart the emergence of psychosis in the context of general psychopathology. Such studies are necessary for establishing developmental trajectories that characterize this emergence and for identifying risk and resilience biomarkers moderating or modulating the full range of schizophrenia-related manifestations. More community-based studies are needed, with better standardization and harmonization of measures and incorporating longitudinal follow-up, to establish mechanistic links between cellular-molecular aberrations and specific manifestations of psychosis as envisioned by the precision medicine agenda.
引用
- Taylor JH, Calkins ME, Gur RE, et al. Markers of Psychosis Risk in the General Population. Biol Psychiatry. 2020. PMID: 32220500. doi:10.1016/j.biopsych.2020.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。